AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$SENS

Senseonics Holdings, Inc.

Price · $SENSvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $SENS in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $SENS in the last 30 days.

Top stories · $SENSMore →
MAY 5·The Manila TimesMed

Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Senseonics Holdings, Inc., a medical technology company focused on continuous glucose monitoring (CGM) systems, announced the successful closing of its $92 million public offering. The offering included common stock and pre-funded warrants, with the underwriters fully exercising their option to purchase additional shares. This capital raise will support the company's ongoing development and commercialization efforts for its implantable CGM devices.

MAY 1·The Manila Times

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Senseonics Holdings, Inc. announced the commencement of an underwritten public offering of its common stock and pre-funded warrants, aiming to raise $80 million. The company plans to use the net proceeds to fund the launch of Eversense 365, continue developing pipeline products, and for general corporate purposes. TD Cowen and Barclays are acting as joint book-running managers for the offering.

MAY 1·Stock Titan

[424B5] Senseonics Holdings, Inc. Prospectus Supplement (Debt Securities)

Senseonics Holdings, Inc. has filed a prospectus supplement for a primary offering of $80 million in common stock and pre-funded warrants. The company intends to use the net proceeds to fund the ongoing launch of its Eversense 365 system, continued pipeline product development, working capital, and general corporate purposes. Preliminary financial estimates for Q1 2026 include approximately $11.7 million in revenue and a net loss between $31 million and $33 million.

News on $SENS

All news →